FGEN vs HPE · rev $29.6M vs P/E 20, rev $32.19B
FibroGen Inc (FGEN) versus Hewlett Packard Enterprise Co (HPE) — a side-by-side from cached financials, not a winner call.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
FGEN currently screens at market cap $39.3M. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Not investment advice. Open the FGEN and HPE stock pages for the full models.
Not investment advice.